Article Details

AstraZeneca drug fails one main goal in study of chronic immune disease - Express Pharma

Retrieved on: 2022-10-26 09:40:57

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca drug fails one main goal in study of chronic immune disease - Express Pharma. View article details on HISWAI: https://www.expresspharma.in/astrazeneca-drug-fails-one-main-goal-in-study-of-chronic-immune-disease/

Excerpt

AstraZeneca said yesterday that its asthma drug Fasenra failed to meet one of the two main goals of a late-stage study assessing the treatment's ...

Article found on: www.expresspharma.in

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up